Cargando…
Clinical outcomes and immune benefits of anti-epileptic drug therapy in HIV/AIDS
BACKGROUND: Anti-epileptic drugs (AEDs) are frequently prescribed to persons with HIV/AIDS receiving combination antiretroviral therapy (cART) although the extent of AED use and their interactions with cART are uncertain. Herein, AED usage, associated toxicities and immune consequences were investig...
Autores principales: | Lee, Kathy, Vivithanaporn, Pornpun, Siemieniuk, Reed A, Krentz, Hartmut B, Maingat, Ferdinand, Gill, M John, Power, Christopher |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2902446/ https://www.ncbi.nlm.nih.gov/pubmed/20565780 http://dx.doi.org/10.1186/1471-2377-10-44 |
Ejemplares similares
-
Interactions between human immunodeficiency virus (HIV)-1 Vpr expression and innate immunity influence neurovirulence
por: Na, Hong, et al.
Publicado: (2011) -
Hepatitis C Virus Core Protein Induces Neuroimmune Activation and Potentiates Human Immunodeficiency Virus-1 Neurotoxicity
por: Vivithanaporn, Pornpun, et al.
Publicado: (2010) -
HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance
por: Vivithanaporn, Pornpun, et al.
Publicado: (2016) -
Brain Microbial Populations in HIV/AIDS: α-Proteobacteria Predominate Independent of Host Immune Status
por: Branton, William G., et al.
Publicado: (2013) -
Anti-Migration and Invasion Effects of Astaxanthin against A172 Human Glioblastoma Cell Line
por: Siangcham, Tanapan, et al.
Publicado: (2020)